In particular, ACP2 has been associated with progressive supranuclear palsy [8] and ACP2 activity levels are known to be increased in juvenile neuronal ceroid lipofuscinosis, a disease caused by mutations in the lysosomal protein CLN3 (Batten disease: [9]). Here, CLN3 is linked to juvenile neuronal ceroid lipofuscinosis.